- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Exenatide – July 2015
Exenatide; 2 mg, powder for injection, vial; Bydureon®
Last updated
1 November 2015